Οκτ62015Βιβλιογραφικά δεδομέναΓια να δείτε το άρθρο πιέστε εδώ Κατηγορία Βιβλιογραφικά δεδομένα6 Οκτωβρίου 2015 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:Statin use and non-alcoholic steatohepatitis in at risk individualsΕπόμενοNext post:Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinomaΣχετικά ΆρθραPhase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection17 Ιουνίου 2026Physical frailty is the most important predictor of early mortality in hospitalized patients with decompensated cirrhosis15 Ιουνίου 2026Liver transplantation is the major determinant of > 10-year survival in patients with hepatocellular carcinoma14 Μαΐου 2026Geographic disparities in hepatitis B vaccine coverage across Africa: Implications for targeted interventions and 2030 goals8 Μαΐου 2026Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis6 Μαΐου 2026Risk of de novo HCC in patients with MASLD following direct-acting antiviral – induced cure of HCV infection24 Απριλίου 2026
Physical frailty is the most important predictor of early mortality in hospitalized patients with decompensated cirrhosis15 Ιουνίου 2026
Liver transplantation is the major determinant of > 10-year survival in patients with hepatocellular carcinoma14 Μαΐου 2026
Geographic disparities in hepatitis B vaccine coverage across Africa: Implications for targeted interventions and 2030 goals8 Μαΐου 2026
Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis6 Μαΐου 2026
Risk of de novo HCC in patients with MASLD following direct-acting antiviral – induced cure of HCV infection24 Απριλίου 2026
